XML 67 R32.htm IDEA: XBRL DOCUMENT v3.22.1
General (Details)
12 Months Ended
Dec. 31, 2021
USD ($)
Accounting Policies [Abstract]  
Clinical trial on outcomes The data demonstrated a median duration of response of 16 months (range 5-36 months), an overall survival at two years of 78% (95% CI, 51%–91%) and a safety profile similar to that reported previously.
Accumulated deficit $ 337,457
Cash $ 81,760
Operating segment 1